The new frontier: assessing efficacy and safety of CGTs using biomarkers
Carlon Fitzpatrick AI Summit
Challenges and solutions in monitoring assay performance for vaccine development
ADA detection and characterization for immunogenicity testing: insights from ICON's Lindsay Denhoff
Tech Blast | Epitope binning
Using the Gyrolab® platform for oligo quantification: an interview with John Chappell
The new frontier: qPCR vs ddPCR for cell and gene therapies
The new frontier: using LC–MS/MS for quantitative assays to support gene therapies
Breaking down barriers for women in tech: an interview with Tina Marshall
Uncovering the link between cancer disparities and climate change
AI-driven early disease detection: an interview with Jim Kean
The new frontier: immunogenicity testing for cell and gene therapies with Johanna Mora
The new frontier: regulatory implications for cell and gene therapies with Kimberley Buytaert-Hoefen
AI and the UK Biobank: an interview with Mahesh Pancholi
Beyond the Abstract: an interview with Hetal Sarvaiya and Yuting Wang
Virtual reality therapies for mental health: Marta Matamala-Gomez
An interview with Namshik Han: predicting protein structure with AI
Tech Blast | Surface plasmon resonance
Beyond the Abstract: an interview with Ashley Phillips
Beyond the Abstract: an interview with Camilla Linder & Miguel Barroso
Create your
podcast in
minutes
It is Free
Earthfiles Podcast with Linda Moulton Howe
DNA Today: A Genetics Podcast
The Psychic Elephant Radio Podcast
Sasquatch Chronicles
Hidden Brain